drugset / Trial / NCT04616001
IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this Pilot Study is to establish a hypothesis of whether or not intravenous immunoglobulin (IVIG) may impact the hospital length of stay, if started within 48 of mechanical ventilation in patients infected with SARS-CoV-2 virus.
Timeline
- Start
- 2020-11-01
- Primary completion
- 2021-06-30
- Completion
- 2021-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Immune Globulin Intravenous (Human) | Protein / enzyme biologic | 0.5 g/kg | Intravenous |